Influence of Maternal Age and Ovarian Reserve on the Decision to Continue or to Cancel IVF Cycles in Patients with One or Two Large Follicles: a Dual Effect.
Antral follicle count
Number of follicles
Poor responders
Journal
Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
24
01
2021
accepted:
30
05
2021
pubmed:
12
6
2021
medline:
12
3
2022
entrez:
11
6
2021
Statut:
ppublish
Résumé
This study aimed to study whether IVF stimulation that results in one or two mature follicles should proceed to oocyte retrieval. This is a retrospective cohort study conducted at McGill University Health Center on 459 patients who underwent IVF treatment between 2011 and 2014, undergoing hormonal stimulation and monitoring of their ovarian response. The primary outcomes were pregnancy and live birth rates. Statistical modeling was used to determine individual roles of patient age and ovarian reserve on outcomes, while controlling for the other factors. Of the 459 cycles included in the study, 360 cycles (78.4%) ended in embryo transfer. Live birth rates per cycle were 15.6%, for the ≤ 34-year-olds; 6.5%, for the 35-39-year-olds; and 2.7%, for the ≥ 40-year-olds (p < 0.01). Twenty-five percent of the cycles in the ≥ 40-year-old group were canceled versus 17% and 15% in the 35-39-year-old and ≤ 34-year-old groups, respectively (p < 0.05). Testing likelihood of live birth as a function of age and antral follicular count (AFC) revealed that a 1-year increase in age reduces the likelihood of live birth by 11% (p < 0.05) and one-unit increase in AFC count leads to a 9% increase in the odds of a live birth (p < 0.05). For the youngest age group, the AFC had a most significant effect, and those with AFC > 11 had 56% live birth rate, while those with AFC ≤ 11 had only 6% of live birth rate. This study supports a shift in reasoning from age being the predictor of outcomes in women with a low response at IVF to both age and ovarian reserve needing to be taken into consideration.
Identifiants
pubmed: 34115367
doi: 10.1007/s43032-021-00649-5
pii: 10.1007/s43032-021-00649-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
291-300Informations de copyright
© 2021. Society for Reproductive Investigation.
Références
Satwik R, Gupta S, Kochhar M, Majumdar A. Anti-Mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization. J Hum Reprod Sci. 2012;5:206–12. https://doi.org/10.4103/0974-1208.101023 .
doi: 10.4103/0974-1208.101023
pubmed: 23162361
pmcid: 3493837
Alviggi C, Andersen CY, Buehler K, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105:1452–3.
doi: 10.1016/j.fertnstert.2016.02.005
Baka S, Makrakis E, Tzanakaki D, et al. Poor responders in IVF: Cancellation of a first cycle is not predictive of a subsequent failure. In: Annals of the New York Academy of Sciences: John Wiley & Sons, Ltd (10.1111); 2006. p. 418–25.
Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome. F1000Research. 2016;5:2911. https://doi.org/10.12688/f1000research.10382.1 .
doi: 10.12688/f1000research.10382.1
pubmed: 28232864
pmcid: 5302217
Zakhari A, Ates S, Shaulov T, Dahan MH. Does ovarian reserve affect outcomes in single ideal blastocyst transfers in women less than 40 years of age? Arch Gynecol Obstet. 2018;297:233–9. https://doi.org/10.1007/s00404-017-4571-x .
doi: 10.1007/s00404-017-4571-x
pubmed: 29082421
Tannus S, Tan J, Son WY, Dahan MH. Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care. Arch Gynecol Obstet. 2018;297:1037–42. https://doi.org/10.1007/s00404-017-4642-z .
doi: 10.1007/s00404-017-4642-z
pubmed: 29289990
Cohen Y, Tannus S, Alzawawi N, Son WY, Dahan M, Buckett W. Poor ovarian response as a predictor for live birth in older women undergoing IVF. Reprod BioMed Online. 2018;36:435–41. https://doi.org/10.1016/j.rbmo.2018.01.008 .
doi: 10.1016/j.rbmo.2018.01.008
pubmed: 29478839
Biljan MM, Buckett WM, Dean N, Phillips SJ, Tan SL. The outcome of IVF-embryo transfer treatment in patients who develop three follicles or less. Hum Reprod. 2000;15:2140–4. https://doi.org/10.1093/humrep/15.10.2140 .
doi: 10.1093/humrep/15.10.2140
pubmed: 11006187
Oudendijk JF, Yarde F, Eijkemans MJC, Broekmans FJM, Broer SL. The poor responder in IVF: Is the prognosis always poor? A systematic review. Hum Reprod Update. 2012;18:1–11.
doi: 10.1093/humupd/dmr037
Ulug U, Ben-Shlomo I, Turan E, Erden HF, Akman MA, Bahceci M. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod BioMed Online. 2003;6:439–43. https://doi.org/10.1016/S1472-6483(10)62164-5 .
doi: 10.1016/S1472-6483(10)62164-5
pubmed: 12831590
Timeva T, Milachich T, Antonova I, Arabaji T, Shterev A, Omar HA. Correlation between number of retrieved oocytes and pregnancy rate after in vitro fertilization/intracytoplasmic sperm infection. ScientificWorldJournal. 2006;6:686–90. https://doi.org/10.1100/tsw.2006.145 .
doi: 10.1100/tsw.2006.145
pubmed: 16799739
pmcid: 5917351
Reichman DE, Gunnala V, Meyer L, Spandorfer S, Schattman G, Davis OK, et al. In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation? Fertil Steril. 2013;100:94–9. https://doi.org/10.1016/j.fertnstert.2013.02.049 .
doi: 10.1016/j.fertnstert.2013.02.049
pubmed: 23615126
Dahan MH, Agdi M, Shehata F, Son WY, Tan SL. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ova. Eur J Obstet Gynecol Reprod Biol. 2014;172:70–3. https://doi.org/10.1016/j.ejogrb.2013.10.027 .
doi: 10.1016/j.ejogrb.2013.10.027
pubmed: 24314801
Alpha Scientists in Reproductive Medicine, ESHRE Special Interest Group Embryology. Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Reprod BioMed Online. 2011;22:632–46. https://doi.org/10.1016/j.rbmo.2011.02.001 .
doi: 10.1016/j.rbmo.2011.02.001
Alpha Scientists in Reproductive Medicine, ESHRE Special Interest Group Embryology, Gardner D, et al. Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Reprod BioMed Online. 2011;22:632–46. https://doi.org/10.1016/j.rbmo.2011.02.001 .
doi: 10.1016/j.rbmo.2011.02.001
Gardner D, Schoolcraft W. In vitro culture of human blastocyst. In: Jansen R, editor. Towards reproductive certainty: infertility and genetics beyond 1999. Carnforth: Parthenon Press; 1999. p. 378–88.
Fox J, Weisberg S. Visualizing fit and lack of fit in complex regression models with predictor effect plots and partial residuals. J Stat Softw. 2018;87:1–27. https://doi.org/10.18637/jss.v087.i09 .
doi: 10.18637/jss.v087.i09
Frank E (2019) Hmisc: Harrell Miscellaneous
Vansteelandt S, Daniel RM. Interventional effects for mediation analysis with multiple mediators. Epidemiology. 2017;28:258–65. https://doi.org/10.1097/EDE.0000000000000596 .
doi: 10.1097/EDE.0000000000000596
pubmed: 27922534
pmcid: 5289540
Chan G (2020) CRAN - Package intmed. https://cran.r-project.org/web/packages/intmed/index.html . Accessed 13 Apr 2021
Ferraretti AP, La Marca A, Fauser BCJM, et al. ESHRE consensus on the definition of poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–24. https://doi.org/10.1093/humrep/der092 .
doi: 10.1093/humrep/der092
pubmed: 21505041
Land JA, Yarmolinskaya MI, Dumoulin JCM, Evers JLH. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril. 1996;65:961–5. https://doi.org/10.1016/S0015-0282(16)58269-7 .
doi: 10.1016/S0015-0282(16)58269-7
pubmed: 8612857
Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O, et al. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet. 2013;30:657–65. https://doi.org/10.1007/s10815-013-9975-3 .
doi: 10.1007/s10815-013-9975-3
pubmed: 23508679
pmcid: 3663963
Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. The role of antiMullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705–14. https://doi.org/10.1016/j.fertnstert.2007.12.013 .
doi: 10.1016/j.fertnstert.2007.12.013
pubmed: 18321493
Son WY, Chung JT, Dahan M, et al. Comparison of fertilization and embryonic development in sibling in vivo matured oocytes retrieved from different sizes follicles from in vitro maturation cycles. In: Journal of Assisted Reproduction and Genetics; 2011. p. 539–44.